0001628280-22-026879.txt : 20221024 0001628280-22-026879.hdr.sgml : 20221024 20221024161420 ACCESSION NUMBER: 0001628280-22-026879 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221020 FILED AS OF DATE: 20221024 DATE AS OF CHANGE: 20221024 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Anevski Peter CENTRAL INDEX KEY: 0001576147 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39100 FILM NUMBER: 221326192 MAIL ADDRESS: STREET 1: C/O PROGYNY, INC. STREET 2: 1359 BROADWAY, 2ND FLOOR CITY: NEW YORK STATE: NY ZIP: 10018 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Progyny, Inc. CENTRAL INDEX KEY: 0001551306 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] IRS NUMBER: 272220139 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1359 BROADWAY STREET 2: 2ND FLOOR CITY: NEW YORK STATE: NY ZIP: 10018 BUSINESS PHONE: 212-888-3124 MAIL ADDRESS: STREET 1: 1359 BROADWAY STREET 2: 2ND FLOOR CITY: NEW YORK STATE: NY ZIP: 10018 FORMER COMPANY: FORMER CONFORMED NAME: Auxogyn, Inc. DATE OF NAME CHANGE: 20150318 FORMER COMPANY: FORMER CONFORMED NAME: Auxogyn Inc DATE OF NAME CHANGE: 20120601 4 1 wf-form4_166664237159873.xml FORM 4 X0306 4 2022-10-20 0 0001551306 Progyny, Inc. PGNY 0001576147 Anevski Peter C/O PROGYNY, INC. 1359 BROADWAY, 2ND FLOOR NEW YORK NY 10018 1 1 0 0 CHIEF EXECUTIVE OFFICER Common Stock 2022-10-20 4 M 0 2248 3.95 A 252693 D Common Stock 2022-10-20 4 S 0 2248 39.38 D 250445 D Common Stock 2022-10-20 4 S 0 562 39.38 D 185575 I See footnote Option (Right to Buy) 3.95 2022-10-20 4 M 0 2248 0 D 2029-05-23 Common Stock 2248.0 1471465 D Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.36 to $39.47, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. One-fourth (1/4th) of the shares subject to the Option vested on May 23, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. /s/ Mark Livingston, Attorney-in-Fact 2022-10-24